---
title: "002940.SZ (002940.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002940.SZ/news.md"
symbol: "002940.SZ"
name: "002940.SZ"
parent: "https://longbridge.com/en/quote/002940.SZ.md"
datetime: "2026-05-20T10:12:37.847Z"
locales:
  - [en](https://longbridge.com/en/quote/002940.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002940.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002940.SZ/news.md)
---

# 002940.SZ (002940.SZ) — Related News

### [ALK: Obtained the drug registration certificate for Rosuvastatin and Ezetimibe Tablets](https://longbridge.com/en/news/286533011.md)
*2026-05-15T08:43:00.000Z*
> ALK announced that the company recently received the "Drug Registration Certificate" for Rosuvastatin and Ezetimibe Tabl

### [ALK stock trading shows abnormal fluctuations, with uncertainties in research projects and private placements](https://longbridge.com/en/news/286635480.md)
*2026-05-15T02:19:19.000Z*
> ALK (002940) announced that its stock trading has experienced unusual fluctuations, and the employee stock ownership pla

### [2 consecutive trading limits for ALK: The company currently has only 1 innovative drug project under research, which is still in the Phase I clinical trial stage](https://longbridge.com/en/news/286389309.md)
*2026-05-14T09:04:13.000Z*
> ALK announced on May 14th that it was identified as experiencing abnormal fluctuations due to its stock price increasing

### [2 consecutive trading days of ALK: Current operating conditions are normal, and there have been no significant changes in the internal and external operating environment](https://longbridge.com/en/news/286386806.md)
*2026-05-14T08:57:38.000Z*
> ALK announced that due to the stock price increasing by more than 20% for two consecutive trading days, it constitutes a

### [The innovative drug concept performs actively, ALK has two consecutive limit-ups](https://longbridge.com/en/news/286340203.md)
*2026-05-14T01:35:47.000Z*
> The innovative drug concept performed actively, with ALK hitting the daily limit and achieving a two-day consecutive ris

### [【Stocks in Motion】Yesterday, the sector with more than two boards fell, and SACRED SUN (002580.CN) dropped 10.0%](https://longbridge.com/en/news/283449540.md)
*2026-04-21T06:30:20.000Z*
> In today's midday trading, the sectors that performed well yesterday with more than two boards have declined. SACRED SUN

### [ALK: Application for the issuance of stocks to specific objects has been accepted by the Shenzhen Stock Exchange](https://longbridge.com/en/news/283246635.md)
*2026-04-19T08:26:23.000Z*
> ALK announced that on April 17, 2026, it received a notice from the Shenzhen Stock Exchange regarding the acceptance of 

### [ALK: The company currently has only one innovative drug project under research, which is still in the Phase I clinical trial stage](https://longbridge.com/en/news/283246327.md)
*2026-04-19T08:13:58.000Z*
> ALK announced that currently there is only 1 innovative drug project under research, named ALK-N001, which is still in t

### [ALK obtained the registration certificate for Clobetasol Propionate Ointment](https://longbridge.com/en/news/282817425.md)
*2026-04-15T09:32:33.000Z*
> ALK announced that the company has obtained the "Drug Registration Certificate" for Clobetasol Ointment issued by the Na